IL161525A0 - Modified release tamsulosin tablets - Google Patents

Modified release tamsulosin tablets

Info

Publication number: IL161525A0
Authority: IL; Israel
Prior art keywords: modified release; release tamsulosin; tamsulosin tablets; tablets; modified
Prior art date: 2001-11-07

Application number

IL16152502A

Original Assignee

Synthon Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-11-07

Filing date

2002-11-06

Publication date

2004-09-27

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23292437&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL161525(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-11-06 Application filed by Synthon Bv filed Critical Synthon Bv

2004-09-27 Publication of IL161525A0 publication Critical patent/IL161525A0/en

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Inorganic Chemistry (AREA)
Organic Chemistry (AREA)
Urology & Nephrology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

IL16152502A 2001-11-07 2002-11-06 Modified release tamsulosin tablets IL161525A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US33105501P	2001-11-07	2001-11-07
PCT/NL2002/000710 WO2003039531A1 (en)	2001-11-07	2002-11-06	Modified release tamsulosin tablets

Publications (1)

Publication Number	Publication Date
IL161525A0 true IL161525A0 (en)	2004-09-27

Family

ID=23292437

Family Applications (4)

Application Number	Title	Priority Date	Filing Date
IL16149102A IL161491A0 (en)	2001-11-07	2002-11-01	Tamsulosin tablets
IL16152502A IL161525A0 (en)	2001-11-07	2002-11-06	Modified release tamsulosin tablets
IL161491A IL161491A (en)	2001-11-07	2004-04-19	Tamsulosin tablets
IL161525A IL161525A (en)	2001-11-07	2004-04-20	Modified release tamsulosin tablets and unit dosage forms containing the same for the treatment of benign prostatic hyperplasia

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
IL16149102A IL161491A0 (en)	2001-11-07	2002-11-01	Tamsulosin tablets

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
IL161491A IL161491A (en)	2001-11-07	2004-04-19	Tamsulosin tablets
IL161525A IL161525A (en)	2001-11-07	2004-04-20	Modified release tamsulosin tablets and unit dosage forms containing the same for the treatment of benign prostatic hyperplasia

Country Status (21)

Country	Link
US (2)	US20030147950A1 (en)
EP (3)	EP1443917B1 (en)
JP (3)	JP2005512997A (en)
CN (3)	CN1298317C (en)
AT (3)	ATE321544T1 (en)
AU (1)	AU2002301845B2 (en)
CA (2)	CA2465110A1 (en)
CZ (3)	CZ16809U1 (en)
DE (4)	DE20220415U1 (en)
DK (3)	DK1443917T3 (en)
ES (2)	ES2256544T3 (en)
HU (2)	HUP0401978A3 (en)
IL (4)	IL161491A0 (en)
NL (2)	NL1021822C2 (en)
NO (2)	NO20042374L (en)
NZ (2)	NZ532589A (en)
PT (2)	PT1443917E (en)
RU (2)	RU2311903C2 (en)
SI (2)	SI1443917T1 (en)
WO (2)	WO2003039530A1 (en)
ZA (2)	ZA200403281B (en)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2003039530A1 (en) *	2001-11-07	2003-05-15	Synthon B.V.	Tamsulosin tablets
US7018658B2 (en) *	2002-11-14	2006-03-28	Synthon Bv	Pharmaceutical pellets comprising tamsulosin
IN192381B (en) *	2002-12-20	2004-04-10	Ranbaxy Lab
US20040253309A1 (en) *	2003-01-27	2004-12-16	Yamanouchi Pharmaceutical Co., Ltd.	Enteric sustained-release fine particles of tamsulosin and its salt and manufacturing method thereof
US20060147531A1 (en) *	2003-07-01	2006-07-06	Mojca Segula	Tamsulosin core with a coating of polyvinylpyrrolidone and polyfinylacetate
KR100762846B1 (en) *	2003-09-29	2007-10-04	씨제이 주식회사	Sustained-release formulations
US20070122480A1 (en) *	2003-09-29	2007-05-31	Cj Corporation	Sustained release formulations
JP2005104914A (en) *	2003-09-30	2005-04-21	Kyowa Yakuhin Kogyo Kk	Basic agent-containing pharmaceutical preparation
US8197846B2 (en) *	2003-11-10	2012-06-12	Astellas Pharma Inc.	Sustained release pharmaceutical composition
JP2005162737A (en) *	2003-11-10	2005-06-23	Astellas Pharma Inc	Sustained release medicinal composition
JP2005162736A (en) *	2003-11-10	2005-06-23	Astellas Pharma Inc	Sustained release medicinal composition
US8128958B2 (en) *	2003-11-10	2012-03-06	Astellas Pharma Inc.	Sustained release pharmaceutical composition
AU2003286415A1 (en) *	2003-12-03	2005-06-24	Natco Pharma Limited	An improved pharmaceutical formulation containing tamsulosin salt and a process for its preparation
SI21702A (en) *	2004-01-29	2005-08-31	Lek Farmacevtska Druzba Dd	Preparation of amorphous form of tamsulosin
JP4603803B2 (en) *	2004-01-30	2010-12-22	大洋薬品工業株式会社	Controlled release pharmaceutical composition and formulation using the same
PL204079B1 (en) *	2004-08-12	2009-12-31	Inst Farmaceutyczny	Oral solid tamsulozine hydrochloride preparation with prolonged release and method for its manufacture
WO2006055659A2 (en) *	2004-11-15	2006-05-26	Smithkline Beecham Corporation	Fixed dose combination op dutasteride and tamsulosin
BRPI0518396A2 (en)	2004-12-27	2008-11-18	Eisai R&D Man Co Ltd	Anti-Dementia Drug Stabilization Method
US20060246003A1 (en) *	2004-12-27	2006-11-02	Eisai Co. Ltd.	Composition containing anti-dementia drug
US20090208579A1 (en) *	2004-12-27	2009-08-20	Eisai R & D Management Co., Ltd.	Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
US20070129402A1 (en) *	2004-12-27	2007-06-07	Eisai Research Institute	Sustained release formulations
US20060160852A1 (en) *	2004-12-27	2006-07-20	Eisai Co. Ltd.	Composition containing anti-dementia drug
US20060159753A1 (en) *	2004-12-27	2006-07-20	Eisai Co. Ltd.	Matrix type sustained-release preparation containing basic drug or salt thereof
KR100678421B1 (en) *	2005-02-11	2007-02-02	주식회사 씨티씨바이오	Controlled-release formulation containing tamsulosin hydrochloride
WO2006118265A1 (en) *	2005-04-28	2006-11-09	Eisai R & D Management Co., Ltd.	Composition containing antidementia agent
CN1895241B (en) *	2005-07-12	2010-05-12	可隆制药株式会社	Composition of long-acting oral pills of Yansuan Tanshuluoxin and its production method
WO2007017253A1 (en) *	2005-08-10	2007-02-15	Add Advanced Drug Delivery Technologies Ltd.	Oral preparation with controlled release of a benzenesulphonamide
KR20070021806A (en) *	2005-08-19	2007-02-23	(주)아모레퍼시픽	Sustained-release pellet formulation of ?1-receptor antagonist and process for the preparation thereof
KR20070044911A (en) *	2005-10-26	2007-05-02	주식회사 씨티씨바이오	Controlled-release formulation containing tamsulosin hydrochloride
WO2007131804A1 (en) *	2006-05-17	2007-11-22	Synthon B.V.	Tablet composition with a prolonged release of tamsulosin
US20090004284A1 (en) *	2007-06-26	2009-01-01	Watson Pharmaceuticals, Inc.	Controlled release tamsulosin hydrochloride formulation
EP2042169A1 (en) *	2007-09-26	2009-04-01	LEK Pharmaceuticals D.D.	Controlled release tamsulosin hydrochloride tablets and a process of making them
TWI478712B (en)	2008-09-30	2015-04-01	Astellas Pharma Inc	Pharmaceutical composition for modified release
US8465770B2 (en) *	2008-12-24	2013-06-18	Synthon Bv	Low dose controlled release tablet
WO2011122524A1 (en)	2010-03-29	2011-10-06	アステラス製薬株式会社	Controlled release pharmaceutical composition
RU2593771C2 (en)	2010-04-30	2016-08-10	Такеда Фармасьютикал Компани Лимитед	Enteric-coated tablet
US20140335174A1 (en) *	2011-05-25	2014-11-13	Taiho Pharmaceutical Co., Ltd.	Dry-coated tablet containing tegafur, gimeracil and oteracil potassium
CN102579392A (en) *	2012-03-30	2012-07-18	重庆科瑞制药(集团)有限公司	Slow-release preparation containing tamsulosin hydrochloride and preparation method thereof
WO2017186598A1 (en)	2016-04-25	2017-11-02	Synthon B.V.	Modified release tablet composition comprising mirabegron
WO2019072404A1 (en)	2017-10-12	2019-04-18	Synthon B.V.	Modified release tablet composition comprising mirabegron
US10478399B2 (en)	2017-10-12	2019-11-19	Synthon B.V.	Modified release tablet composition comprising mirabegron
EP3292864A1 (en)	2017-10-12	2018-03-14	Synthon B.V.	Modified release tablet composition comprising mirabegron
WO2019076966A1 (en)	2017-10-17	2019-04-25	Synthon B.V.	Tablets comprising tamsulosin and solifenacin

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS56110665A (en) *	1980-02-08	1981-09-01	Yamanouchi Pharmaceut Co Ltd	Sulfamoyl-substituted phenetylamine derivative and its preparation
US5391825A (en) *	1980-02-08	1995-02-21	Yamanouchi Pharmaceutical Co., Ltd.	Sulfamoyl substituted phenethylamine intermediates
US4772475A (en) *	1985-03-08	1988-09-20	Yamanouchi Pharmaceutical Co., Ltd.	Controlled-release multiple units pharmaceutical formulation
EP0205336B1 (en) *	1985-06-11	1991-09-11	Teijin Limited	Oral sustained release pharmaceutical preparation
GB8626098D0 (en) *	1986-10-31	1986-12-03	Euro Celtique Sa	Controlled release hydromorphone composition
IE60311B1 (en) *	1987-09-24	1994-06-29	American Home Prod	Sustained release etodolac
US5478577A (en) *	1993-11-23	1995-12-26	Euroceltique, S.A.	Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
RU2139053C1 (en) *	1992-11-04	1999-10-10	Сепракор, Инк.	Method of enhancing urination in humans
IL109460A (en) *	1993-05-10	1998-03-10	Euro Celtique Sa	Controlled release formulation comprising tramadol
AU7085194A (en) *	1993-07-14	1995-02-13	Yamanouchi Pharmaceutical Co., Ltd.	Remedy for urination disorder accompanying prostatic hypertrophy
US5576014A (en) *	1994-01-31	1996-11-19	Yamanouchi Pharmaceutical Co., Ltd	Intrabuccally dissolving compressed moldings and production process thereof
US5503843A (en) *	1994-04-22	1996-04-02	Flora Inc.	Transdermal delivery of alpha adrenoceptor blocking agents
US5945125A (en) *	1995-02-28	1999-08-31	Temple University	Controlled release tablet
JPH09323926A (en) *	1996-03-15	1997-12-16	Nikken Chem Co Ltd	Sustained release tablet of sodium valproate
JP2001507359A (en) *	1997-01-03	2001-06-05	エランコーポレーションピーエルシー	Sustained release cisapride mini tablet formulation
US5843472A (en) *	1997-02-28	1998-12-01	Cygnus, Inc.	Transdermal drug delivery sytem for the administration of tamsulosin, and related compositions and methods of use
JP4221068B2 (en) *	1997-12-17	2009-02-12	興和創薬株式会社	Theophylline sustained release tablet and method for producing the same
US6099859A (en) *	1998-03-20	2000-08-08	Andrx Pharmaceuticals, Inc.	Controlled release oral tablet having a unitary core
JP2000080032A (en) *	1998-06-26	2000-03-21	Yamanouchi Pharmaceut Co Ltd	Remedy for excretion disorder
TW536402B (en) *	1998-06-26	2003-06-11	Yamanouchi Pharma Co Ltd	Pharmaceutical composition for the therapy of voiding dysfunction
JP2000128774A (en) *	1998-10-26	2000-05-09	Tanabe Seiyaku Co Ltd	Production of globular, fine grain including medicine
US6419960B1 (en) *	1998-12-17	2002-07-16	Euro-Celtique S.A.	Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
US6248363B1 (en) *	1999-11-23	2001-06-19	Lipocine, Inc.	Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
KR100660594B1 (en) *	1999-03-31	2006-12-22	얀센 파마슈티카 엔.브이.	Pregelatinized starch in a controlled release formulation
CA2698347A1 (en) *	1999-05-20	2000-11-30	Elan Pharma International Limited	Multiparticulate controlled release selective serotonin reuptake inhibitor formulations
EP1064938A1 (en) *	1999-06-28	2001-01-03	Sanofi-Synthelabo	Pharmaceutical dosage forms for controlled release producing at least a timed pulse
AR022348A1 (en) *	1999-08-09	2002-09-04	Astellas Pharma Inc	A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF SYMPTOMS OF LOWER URINARY TRACT
JP3154710B1 (en) *	1999-08-09	2001-04-09	山之内製薬株式会社	Lower urinary tract disorders
GB9924020D0 (en) *	1999-10-11	1999-12-15	Pfizer Ltd	Pharmaceutically active compounds
IL141235A (en) *	2000-02-09	2012-04-30	Novartis Int Pharm Ltd	Combined use of an alpha-adrenoceptor antagonist and a muscarinic antagonist in the manufacture of a medicament for the treatment of benign prostatic hyperplasia
GB0008332D0 (en) *	2000-04-04	2000-05-24	Pfizer Ltd	Treament
US6368628B1 (en) *	2000-05-26	2002-04-09	Pharma Pass Llc	Sustained release pharmaceutical composition free of food effect
US6287599B1 (en) *	2000-12-20	2001-09-11	Shire Laboratories, Inc.	Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles
DE10109763A1 (en) *	2001-02-28	2002-09-05	Gruenenthal Gmbh	Pharmaceutical salts
DE20220604U1 (en) *	2001-07-27	2004-02-26	Yamanouchi Pharmaceutical Co., Ltd.	Composition containing fine long-term release particles for tablets that disintegrate quickly in the oral cavity
WO2003039530A1 (en) *	2001-11-07	2003-05-15	Synthon B.V.	Tamsulosin tablets

2002
- 2002-11-01 WO PCT/NL2002/000695 patent/WO2003039530A1/en active IP Right Grant
- 2002-11-01 EP EP02775597A patent/EP1443917B1/en not_active Expired - Lifetime
- 2002-11-01 DE DE20220415U patent/DE20220415U1/en not_active Expired - Lifetime
- 2002-11-01 HU HU0401978A patent/HUP0401978A3/en unknown
- 2002-11-01 SI SI200230306T patent/SI1443917T1/en unknown
- 2002-11-01 IL IL16149102A patent/IL161491A0/en unknown
- 2002-11-01 AT AT02775597T patent/ATE321544T1/en not_active IP Right Cessation
- 2002-11-01 DK DK02775597T patent/DK1443917T3/en active
- 2002-11-01 NL NL1021822A patent/NL1021822C2/en not_active IP Right Cessation
- 2002-11-01 CN CNB028217357A patent/CN1298317C/en not_active Expired - Fee Related
- 2002-11-01 CA CA002465110A patent/CA2465110A1/en not_active Abandoned
- 2002-11-01 PT PT02775597T patent/PT1443917E/en unknown
- 2002-11-01 NZ NZ532589A patent/NZ532589A/en unknown
- 2002-11-01 DE DE60210315T patent/DE60210315T2/en not_active Expired - Lifetime
- 2002-11-01 ES ES02775597T patent/ES2256544T3/en not_active Expired - Lifetime
- 2002-11-01 RU RU2004117081/15A patent/RU2311903C2/en active
- 2002-11-01 ZA ZA200403281A patent/ZA200403281B/en unknown
- 2002-11-01 JP JP2003541821A patent/JP2005512997A/en active Pending
- 2002-11-06 CA CA2464689A patent/CA2464689C/en not_active Expired - Lifetime
- 2002-11-06 AU AU2002301845A patent/AU2002301845B2/en not_active Expired
- 2002-11-06 WO PCT/NL2002/000710 patent/WO2003039531A1/en active IP Right Grant
- 2002-11-06 HU HU0402004A patent/HU230830B1/en unknown
- 2002-11-06 JP JP2003541822A patent/JP2005511591A/en not_active Withdrawn
- 2002-11-06 NL NL1021857A patent/NL1021857C2/en not_active IP Right Cessation
- 2002-11-06 CZ CZ200617349U patent/CZ16809U1/en not_active IP Right Cessation
- 2002-11-06 DE DE60221691.5T patent/DE60221691T3/en not_active Expired - Lifetime
- 2002-11-06 DK DK02780143.0T patent/DK1441713T4/en active
- 2002-11-06 ES ES02780143T patent/ES2287333T5/en not_active Expired - Lifetime
- 2002-11-06 EP EP05017380A patent/EP1595538A3/en not_active Withdrawn
- 2002-11-06 NZ NZ532592A patent/NZ532592A/en not_active IP Right Cessation
- 2002-11-06 PT PT02780143T patent/PT1441713E/en unknown
- 2002-11-06 RU RU2004117080/15A patent/RU2335280C2/en active
- 2002-11-06 CN CN2011102907062A patent/CN102327250A/en active Pending
- 2002-11-06 EP EP02780143.0A patent/EP1441713B2/en not_active Expired - Lifetime
- 2002-11-06 DE DE20221486U patent/DE20221486U1/en not_active Expired - Lifetime
- 2002-11-06 CN CNA028229223A patent/CN1589139A/en active Pending
- 2002-11-06 CZ CZ200617866U patent/CZ16813U1/en not_active IP Right Cessation
- 2002-11-06 SI SI200230592T patent/SI1441713T2/en unknown
- 2002-11-06 IL IL16152502A patent/IL161525A0/en unknown
- 2002-11-06 AT AT02780143T patent/ATE369128T2/en active
- 2002-11-06 CZ CZ200617867U patent/CZ16814U1/en not_active IP Right Cessation
- 2002-11-07 US US10/289,385 patent/US20030147950A1/en not_active Abandoned
- 2002-11-07 US US10/289,387 patent/US20030147955A1/en not_active Abandoned
2004
- 2004-04-19 IL IL161491A patent/IL161491A/en not_active IP Right Cessation
- 2004-04-20 IL IL161525A patent/IL161525A/en active IP Right Grant
- 2004-05-06 ZA ZA200403430A patent/ZA200403430B/en unknown
- 2004-06-07 NO NO20042374A patent/NO20042374L/en not_active Application Discontinuation
- 2004-06-07 NO NO20042375A patent/NO340960B1/en not_active IP Right Cessation
2005
- 2005-12-12 AT AT0084805U patent/AT9978U1/en not_active IP Right Cessation
- 2005-12-22 DK DK200500297U patent/DK200500297U3/en not_active IP Right Cessation
2010
- 2010-10-15 JP JP2010232415A patent/JP5536610B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
HUP0401978A3 (en)	2008-07-28
AT9978U1 (en)	2008-07-15
ES2256544T3 (en)	2006-07-16
DE60221691T3 (en)	2019-04-04
US20030147950A1 (en)	2003-08-07
NO20042375L (en)	2004-08-09
EP1595538A2 (en)	2005-11-16
ES2287333T5 (en)	2019-04-29
DE60221691T2 (en)	2008-04-30
NL1021857C2 (en)	2004-01-09
WO2003039530A1 (en)	2003-05-15
HUP0402004A2 (en)	2005-01-28
DK1441713T4 (en)	2019-02-18
DE60210315T2 (en)	2006-11-02
ATE369128T2 (en)	2007-08-15
IL161491A (en)	2009-07-20
DK1441713T3 (en)	2007-12-17
RU2004117081A (en)	2005-03-20
RU2311903C2 (en)	2007-12-10
DE60210315D1 (en)	2006-05-18
CA2464689C (en)	2011-02-01
NZ532592A (en)	2005-02-25
JP2011051995A (en)	2011-03-17
ES2287333T3 (en)	2007-12-16
CZ16814U1 (en)	2006-08-28
WO2003039531A1 (en)	2003-05-15
IL161491A0 (en)	2004-09-27
SI1441713T2 (en)	2019-03-29
ZA200403281B (en)	2005-12-13
NZ532589A (en)	2005-02-25
DE20221486U1 (en)	2006-02-02
DK1443917T3 (en)	2006-07-17
JP5536610B2 (en)	2014-07-02
CN1589139A (en)	2005-03-02
EP1441713B2 (en)	2018-11-14
CN1298317C (en)	2007-02-07
US20030147955A1 (en)	2003-08-07
CA2464689A1 (en)	2003-05-15
HU230830B1 (en)	2018-07-30
NL1021857A1 (en)	2003-05-08
HUP0401978A2 (en)	2005-01-28
NO20042374L (en)	2004-08-09
DE20220415U1 (en)	2003-10-09
EP1441713A1 (en)	2004-08-04
HUP0402004A3 (en)	2008-08-28
RU2335280C2 (en)	2008-10-10
JP2005512997A (en)	2005-05-12
PT1443917E (en)	2006-06-30
ZA200403430B (en)	2006-02-22
DK200500297U3 (en)	2006-03-10
EP1595538A3 (en)	2006-02-22
PT1441713E (en)	2007-08-28
EP1443917A1 (en)	2004-08-11
CN1652760A (en)	2005-08-10
EP1443917B1 (en)	2006-03-29
NO340960B1 (en)	2017-07-31
JP2005511591A (en)	2005-04-28
AU2002301845B2 (en)	2008-06-05
EP1441713B1 (en)	2007-08-08
CZ16813U1 (en)	2006-08-28
ATE321544T1 (en)	2006-04-15
RU2004117080A (en)	2005-04-10
NL1021822C2 (en)	2003-07-15
SI1441713T1 (en)	2007-10-31
DE60221691D1 (en)	2007-09-20
IL161525A (en)	2012-12-31
CN102327250A (en)	2012-01-25
CZ16809U1 (en)	2006-08-28
SI1443917T1 (en)	2006-06-30
CA2465110A1 (en)	2003-05-15
NL1021822A1 (en)	2003-05-08

Publication	Publication Date	Title
HUP0402004A3 (en)	2008-08-28	Modified release tamsulosin tablets
AU2002301845A1 (en)	2003-06-12	Modified release tamsulosin tablets
TWI347202B (en)	2011-08-21	Controlled release preparation
AU2002327068A1 (en)	2003-04-14	Immediate release tablet
EP1537880A4 (en)	2009-07-01	Sustained release preparation
AU2003241483A8 (en)	2003-11-11	Push release loop
IL159048A0 (en)	2004-05-12	Sustained release formulation
PL369328A1 (en)	2005-04-18	Controlled release tablets of metformin
IL162019A0 (en)	2005-11-20	Mousse
GB0115761D0 (en)	2001-08-22	Capsules
GB0116732D0 (en)	2001-08-29	Heat release substances
AU2002343227A1 (en)	2003-05-19	Modified release tamsulosin tablets
AU2002301844B2 (en)	2007-05-03	Tamsulosin tablets
GB2397950B (en)	2005-06-15	Diplexer
GB2375521B (en)	2004-04-28	Davits
AU2002301844A1 (en)	2003-06-12	Tamsulosin tablets
AU2002341442A1 (en)	2003-05-19	Tamsulosin tablets
GB0130272D0 (en)	2002-02-06	Release device
AU147578S (en)	2002-04-29	Tablet
GB0112144D0 (en)	2001-07-11	Capsules
AU2003229163A1 (en)	2003-11-11	Extended release tablets comprising felodipine
SI1368006T1 (en)	2006-08-31	Novel modified released formulation
AU2002347776A1 (en)	2003-04-07	Modified release dosage forms
AU2002334741A1 (en)	2003-04-07	Modified release dosage forms
AU2002334731A1 (en)	2003-04-07	Modified release dosage forms